Brasada Capital Management LP Buys Shares of 2,526 Danaher Corporation $DHR

Brasada Capital Management LP bought a new stake in Danaher Corporation (NYSE:DHR) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 2,526 shares of the conglomerate’s stock, valued at approximately $1,819,000.

A number of other institutional investors have also recently made changes to their positions in the company. Sivia Capital Partners LLC lifted its stake in shares of Danaher by 6.3% in the second quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock worth $397,000 after buying an additional 119 shares in the last quarter. First Trust Advisors LP boosted its position in Danaher by 34.5% during the second quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock worth $10,947,000 after acquiring an additional 14,217 shares during the last quarter. Main Street Financial Solutions LLC increased its holdings in shares of Danaher by 40.2% in the second quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock valued at $610,000 after purchasing an additional 886 shares during the last quarter. Ieq Capital LLC lifted its position in Danaher by 64.2% during the second quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock worth $14,957,000 after buying an additional 29,592 shares in the last quarter. Finally, HUB Investment Partners LLC grew its holdings in Danaher by 30.7% in the 2nd quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock valued at $273,000 after buying an additional 325 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Stock Up 0.2%

Shares of NYSE:DHR opened at $215.74 on Friday. The business has a 50-day moving average price of $198.69 and a 200 day moving average price of $192.35. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The company has a market capitalization of $151.67 billion, a price-to-earnings ratio of 38.32, a PEG ratio of 2.68 and a beta of 0.78. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. During the same period in the previous year, the firm earned $0.77 EPS. Danaher’s revenue was up 5.5% on a year-over-year basis. Sell-side analysts expect that Danaher Corporation will post 8.53 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on DHR. DZ Bank initiated coverage on shares of Danaher in a report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price objective for the company. TD Cowen reduced their target price on shares of Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Wells Fargo & Company decreased their target price on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a report on Wednesday, July 22nd. Weiss Ratings raised shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, July 15th. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $240.00 price target on shares of Danaher in a report on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $228.91.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.